N25.81
Secondary hyperparathyroidism of renal origin
Clinical Classification Guidelines
Excludes Type 1
- secondary hyperparathyroidism, non-renal (E21.1)
Excludes Type 2
- metabolic disorders classifiable to E70-E88
Medical Intelligence & Overview
Secondary hyperparathyroidism of renal origin is a condition where the parathyroid glands produce too much hormone due to chronic kidney disease. This excess hormone impacts calcium and phosphate balance in the body, leading to various health problems. It typically develops as a complication of ongoing kidney dysfunction, affecting bone health and cardiovascular function.
Causes & Symptoms
Clinical Causes: Chronic kidney disease (CKD), especially in later stages Impaired ability of the kidneys to maintain proper calcium and phosphate levels Vitamin D deficiency or resistance Electrolyte imbalances due to kidney failure Long-term dialysis treatment
Key Symptoms: Bone pain or tenderness Muscle weakness or cramps Itching or skin rash Fatigue or overall feeling of malaise Calcification of soft tissues, including blood vessels and skin Possible development of bone deformities High blood pressure
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves blood tests to measure levels of parathyroid hormone (PTH), calcium, phosphate, and vitamin D. Elevated PTH levels alongside abnormal calcium and phosphate levels suggest secondary hyperparathyroidism. Bone density scans and imaging studies may also be used to assess bone health. A review of the patient’s kidney function and history of chronic kidney disease helps confirm the diagnosis.
Treatment Protocols: Management focuses on controlling hormone levels and maintaining mineral balance. Treatment options include: - Phosphate binders to reduce phosphate absorption - Active vitamin D analogs to suppress PTH production - Dietary modifications to limit phosphate intake - Use of calcimimetics to decrease parathyroid hormone secretion - Maintaining adequate calcium levels through diet or supplements - Regular monitoring of blood minerals and hormone levels - In some cases, surgical removal of overactive parathyroid glands (parathyroidectomy) may be considered Effective management can help reduce the risk of bone disease and cardiovascular problems associated with this condition.
Clinical Advice & FAQs
Billing Guidance
Is N25.81 a billable ICD-10 code?
Yes, N25.81 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report N25.81?
Clinical documentation must specify the nature of Secondary hyperparathyroidism of renal origin and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
